Cargando…
Decentralized clinical trials (DCTs): A few ethical considerations
Decentralized clinical trials (DCTs) are studies in which the need for patients to physically access hospital-based trial sites is reduced or eliminated. The CoViD-19 pandemic has caused a significant increase in DCT: a survey shows that 76% of pharmaceutical companies, device manufacturers, and Con...
Autores principales: | Petrini, Carlo, Mannelli, Chiara, Riva, Luciana, Gainotti, Sabina, Gussoni, Gualberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797802/ https://www.ncbi.nlm.nih.gov/pubmed/36590004 http://dx.doi.org/10.3389/fpubh.2022.1081150 |
Ejemplares similares
-
A few ethical issues in translational research for gene and cell therapy
por: Riva, Luciana, et al.
Publicado: (2019) -
Initial experience of DCTs
por: Mehdizadeh, R., et al.
Publicado: (2020) -
End nomadic DCTs
por: Bradley, A.
Publicado: (2022) -
191 Ethical Considerations of Decentralized Clinical Trials
por: Pascalev, Assya
Publicado: (2022) -
Ethical Considerations for Unblinding and Vaccinating COVID-19 Vaccine Trial Placebo Group Participants
por: Stoehr, Jenna Rose, et al.
Publicado: (2021)